Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mallinckrodt to Acquire Ocera Therapeutics, OCR-002

americanpharmaceuticacreviewNovember 03, 2017

Tag: Mallinckrodt , Ocera , OCR-002

PharmaSources Customer Service